Shire PLC said it has agreed to buy NPS Pharmaceuticals Inc. for $5.2 billion in a takeover that would mark the Irish drug maker’s return to deal-making.
via WSJ.com: US Business http://ift.tt/1FIPDIg
via WSJ.com: US Business http://ift.tt/1FIPDIg
Nessun commento:
Posta un commento